CTBR members Michael A. Hoyt and Tracey A. Revenson named Editors-in-Cheif of the International Journal of Behavioral Medicine
Drs. Michael A. Hoyt and Tracey A. Revenson have been named as the new Editors-in-Chief of theInternational Journal of Behavioral Medicine...
Learn how diversity supports the NIH mission, find opportunities to participate in diversity programs, meet researchers, and more. Whether you are a science student, trainee, faculty member, or someone who is interested in diversity programs, you can find what you are looking for on the NIH Diversity in Extramural Programs website.
CTBR Member Tracy Dennis-Tiwary weighs in on how to talk to children who are upset by the news: What If My Kid Is Scared By the News? What Do I Do?
BELFER/HUNTER Retreat President Jennifer Raab has designated Wednesday, January 4th for the Belfer/Hunter symposium. This day-long event will conclude with a cocktail reception at 05:00 pm attended by the President of Hunter and the Dean of the Weill Cornell Medical School. This symposium is designed to foster collaborations between the Hunter researchers at Belfer and the researchers at Weill...
CTBR member Mandë Holford and collaborator Jessica Ochoa Hendrix presented the winning story in Tell Me Something I Don’t Know! The duo competed in Episode 2: It’s Alive! which featured “Tales from the natural world.” TMSIDK, the most downloaded podcast on iTunes, is a live game show hosted by Stephen J. Dubner, co-author of the Freakonomics books and host of Freakonomics Radio. In the show...
RTRN SMALL GRANTS PROGRAM RESEARCH ENHANCEMENT AWARD - CYCLE 2
FOA Release Date: December 5, 2016
Application Due Date: January 16, 2017
A strategic goal of the...
CTBR Member and Chemistry Professor Hiroshi Matsui Leads Belfer Team in Trailblazing Cancer Research
Matsui, an expert in bio-nanotechnology, is the lead author of a groundbreaking study just published in Nano Letters, a prominent academic journal. Matsui’s article documents his Hunter lab’s discovery of a tiny new anti-cancer drug carrier. This nanoparticle-based carrier promises to replace current drug-delivery methods and dramatically improve treatment for metastatic osteosarcoma.
Jeffrey Parsons, Chest Director and CTBR Member Interviewed by POV Magazine in honor of the Group's 20th Anniversary
Click here to read the interview!
From POV Magazine